Clinical Trial Detail

NCT ID NCT03786796
Title Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations (ORCHID)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

renal cell carcinoma

Therapies

Olaparib

Age Groups: senior adult

Additional content available in CKB BOOST